Dr. Riddhishkumar Shah
Claim this profileDuke Cancer Institute Cary
Studies Colon Cancer
Studies Colorectal Cancer
3 reported clinical trials
12 drugs studied
Area of expertise
1Colon Cancer
Stage II
Stage III
MSS positive
2Colorectal Cancer
Stage II
Stage III
MSS positive
Affiliated Hospitals
Clinical Trials Riddhishkumar Shah is currently running
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting1 award Phase 2 & 3
Biomarker-Guided Immunotherapy Discontinuation
for Melanoma
This trial uses drugs that boost the immune system to fight advanced melanoma that can't be surgically removed. It aims to see if doctors can safely shorten the treatment period by using imaging tests to guide decisions. Pembrolizumab and ipilimumab are immunotherapy drugs used to treat advanced melanoma, with pembrolizumab approved for younger patients and ipilimumab showing positive results in previous studies.
Recruiting1 award Phase 222 criteria
More about Riddhishkumar Shah
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Riddhishkumar Shah has experience with
- Capecitabine
- Fluorouracil
- Leucovorin
- Leucovorin Calcium
- Oxaliplatin
- CAPOX
Breakdown of trials Riddhishkumar Shah has run
Colon Cancer
Colorectal Cancer
Cutaneous Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Riddhishkumar Shah specialize in?
Riddhishkumar Shah focuses on Colon Cancer and Colorectal Cancer. In particular, much of their work with Colon Cancer has involved Stage II patients, or patients who are Stage III.
Is Riddhishkumar Shah currently recruiting for clinical trials?
Yes, Riddhishkumar Shah is currently recruiting for 2 clinical trials in Cary North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Riddhishkumar Shah has studied deeply?
Yes, Riddhishkumar Shah has studied treatments such as Capecitabine, Fluorouracil, Leucovorin.
What is the best way to schedule an appointment with Riddhishkumar Shah?
Apply for one of the trials that Riddhishkumar Shah is conducting.
What is the office address of Riddhishkumar Shah?
The office of Riddhishkumar Shah is located at: Duke Cancer Institute Cary, Cary, North Carolina 27518 United States. This is the address for their practice at the Duke Cancer Institute Cary.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.